Leave Your Message
islayidi1

Ipulatifomu Yokuthuthukiswa Kwama-Antibody Angama-Bispecific

I-Alpha Lifetech inganikeza amakhasimende ukutholakala kwama-antibody aqinisekisiwe ngekhwalithi kanye nemikhiqizo nezinsizakalo zamaphrotheni aphinde ahlanganiswe.

Cela Isilinganiso
01

Ipulatifomu Yokuthuthukiswa Kwama-Antibody Angama-Bispecific

I-Alpha Lifetech ingahlinzeka amakhasimende ngekhwalithi yokutholwa kwama-antibody aqinisekisiwe kanye nemikhiqizo nezinsizakalo zamaphrotheni ahlanganisiwe. Singalungisa ama-antibodies ngempumelelo ephezulu, ukucaciswa okuqinile, kanye nokuqina okuhle. I-Alpha Lifetech inezinhlobonhlobo zezinsimbi zokuhlanza ama-antibody kanye nemishini, engahlinzeka ngezinsizakalo zokuhlanza ama-antibody ezivela emithonjeni ehlukahlukene njenge-antibody yonogwaja, imvu, inkukhu, kanye negundane, kanye nezinsizakalo zokuhlanza ama-affinity e-Protein A/G kanye nezinsizakalo zokuhlukanisa nokuhlanzwa kwama-antibody. Ngokusekelwe ekwakhiweni kwesistimu yesikhulumi esiphelele sepulatifomu yokuthola ama-antibody, ipulatifomu yamaphrotheni, njll., simboza izinsizakalo ezisezingeni eliphezulu neziphansi zokukhiqizwa kwama-antibody, futhi singahlinzeka ngezinsizakalo zobuchwepheshe ezivela ekulungiseleleni ama-antibody, ukuhlanzwa kwama-antibody amabili kanye nokuhlukaniswa nokuhlanzwa kwama-antibody, ukulandelana kwama-antibody, ukuqinisekiswa kwama-antibody, njll., ezingasetshenziswa ekwelashweni kwama-antibody amabili.

Ama-antibodies e-Monoclonal abhekisela kuma-immunoglobulins akhiqizwa yiseli elilodwa le-B elinobuchwepheshe obuphezulu bama-antigen noma ama-epitopes. Ukukhiqizwa kwama-antibodies e-Monoclonal kwaqalwa kwalungiswa kusetshenziswa ubuchwepheshe be-hybridoma ukukhiqiza ama-antibodies egundane. Ngokukhethekile, ngokuhlanganisa amaseli e-spleen avela kumagundane agonyiwe namaseli e-myeloma avela kubantu noma emagundwini, kwakheka amaseli e-hybridoma, akhipha ama-antibodies athile. Ama-antibodies e-monoclonal egundane akhiqizwayo asetshenziswa kakhulu ocwaningweni lwezilwane kanye nokuxilongwa kwezifo ngemuva kwezinsizakalo zokuhlanzwa. Kodwa-ke, umzimba womuntu uzokhiqiza impendulo yokuzivikela kumaprotheni egundane angaphandle, ngakho-ke kunemikhawulo ebalulekile ekusetshenzisweni kwemitholampilo kokukhiqizwa kwama-antibodies e-monoclonal egundane. Kamuva, abantu basebenzisa "ukwenziwa kwabantu" ukulungiselela ama-antibodies e-monoclonal avela emagundwini, futhi basebenzisa ubuchwepheshe bobunjiniyela bezakhi zofuzo ukuguqula ama-antibodies egundane ukuze abe nesifunda esiqhubekayo se-immunoglobulin yomuntu ukunciphisa ukuqina kwawo kwe-immunogenicity. Lolu hlobo lwe-antibody lwaziwa nangokuthi i-humanized monoclonal antibody. Ngaphezu kwalokho, ukusebenzisa amaseli abantu ukukhiqiza ama-antibodies e-monoclonal kubizwa ngokuthi ukulungiswa kwama-antibody e-monoclonal yomuntu wonke. Ama-antibodies e-monoclonal asetshenziswa kabanzi ekusetshenzisweni kwezokwelapha kanye nokwelashwa. Ocwaningweni lwezokwelapha, ama-antibodies e-monoclonal angasetshenziswa njenge-immunomodulators, ama-antibodies e-monoclonal okwelapha angasetshenziswa ekwelashweni ngamakhemikhali omdlavuza kanye nokwelashwa kokutheleleka ngegciwane, kanti ukuthuthukiswa kwama-conjugates e-monoclonal antibody kusetshenziselwa kakhulu ukwelashwa komdlavuza.

Isingeniso ku-Bispecific Antibody

Ngo-1960, kwaphakanyiswa umqondo wama-antibodies e-bispecific. Ama-antibodies e-bispecific, aziwa nangokuthi ama-antibodies e-bispecific monoclonal, angama-antibodies akhiwe ngokwenziwa kusetshenziswa ubuchwepheshe bobunjiniyela bezakhi zofuzo. Njenge-antibody yokwenziwa eyenziwe ngobunjiniyela, ama-antibodies e-bispecific ngokuvamile ayingxenye ye-IgG futhi aqukethe ingxenye yokubopha i-antigen eqondise i-subunit ye-CD3. Ama-antibodies e-bispecific anezindawo ezimbili ezithile zokubopha i-antigen ezingabopha futhi zibone ama-antigen amabili ahlukene ngasikhathi sinye, noma ama-epitopes amabili ahlukene e-antigen. Uma kuqhathaniswa nama-antibodies e-monoclonal, ama-antibodies e-bispecific anesinye isayithi sokubopha i-antigen esithile, ngaleyo ndlela abe nokucaciswa okuqinile nekhono lokuqondisa, okungaqondisa ngokunembile amaseli esimila futhi kuncishiswe ubuthi obungaqondiwe. Ama-antibodies e-bispecific angenza imisebenzi eminingi yebhayoloji ngasikhathi sinye, njengokuqasha amaseli omzimba, ukuvimba izindlela zokubonisa izimpawu, nokubulala amaseli esimila ngokuqondile. Ama-antibodies okuqala e-bispecific alungiswa kakhulu ngokuhlanganiswa kwamakhemikhali noma ukuhlanganiswa kwamaseli, kodwa le ndlela kungenzeka ukuthi yathuthuka kancane ngenxa yokuhlanganiswa okungahleliwe kanye nobunzima bokuhlukanisa inhlanganisela yokuqondisa. Ngokuthuthuka okuqhubekayo kobuchwepheshe bobunjiniyela bezakhi zofuzo, kuye kwasungulwa amapulatifomu amaningi amasha obuchwepheshe, njenge-knots in holes (KIH), i-CrossMab, i-DVD Ig, njll. Lawa mapulatifomu axazulula ngempumelelo izinkinga ezifana nokungafani kwe-heavy chain kanye ne-light chain, futhi athuthukise ukufana kanye nokukhiqizwa kwama-antibodies e-bispecific.
ama-bsAb
Isithombe 1 Ukubuka konke okulula kwesimiso sezindlela eziphakanyisiwe zokusebenza kwama-antibodies e-bispecific (bsAbs) ekuhlolweni kwemitholampilo kwe-oncology.(Umthombo wesithombe: Ukubuyekezwa kwama-antibodies e-bispecific kanye nokwakheka kwama-antibody ku-oncology kanye nezinselele zezokwelapha - ScienceDirect)

Ubuchwepheshe Bokukhiqiza Ama-Antibodies Ahlukene Ahlukene

Izindlela eziyinhloko zokukhiqizwa kwama-antibody amabili zihlanganisa ukuhlanganiswa kwamakhemikhali, i-hybridoma yomthombo emine, kanye nokulungiswa kwama-antibody obunjiniyela bezakhi zofuzo. Phakathi kwazo, indlela yokuhlanganiswa kwamakhemikhali ihlanganisa izingcezu ezimbili ze-antibody ze-IgG noma ezimbili ze-F (ab ') 2 eziphelele kuma-antibody amabili asebenzisa ama-agent okuhlanganisa amakhemikhali njenge-phthalimide kanye ne-dithioacylbenzoic acid. Le ndlela ilula futhi kulula ukuyisebenzisa, kodwa ingalimaza indawo yokubopha i-antigen, inciphise umsebenzi wama-antibody, futhi i-agent yokuhlanganisa ngokwayo inezinga elithile lokuba nomdlavuza. Indlela ye-hybridoma yomthombo emine isekelwe ekuhlanganisweni kwamaseli e-somatic avela emigqeni emibili ehlukene yamaseli e-hybridoma ukuveza i-IgG yegundane ehambisanayo. Ngobuchwepheshe bobunjiniyela bezakhi zofuzo, ama-antibodies angaguqulwa ngezakhi zofuzo ukuze akhe ama-antibody amabili ahlukile. Ama-antibody amabili ahlukene e-monoclonal akhiwa, futhi izingcezu ze-Fab noma izifunda eziguquguqukayo zeketanga elisindayo kanye neketanga elikhanyayo lama-antibody amabili zahlukaniswa ngokwehlukana. Ngobuchwepheshe bokusabela okuxhumene noma bokuhlukaniswa kweketanga, izingcezu ezimbili zahlanganiswa ukuze zakhe i-antibody amabili ahlukile. Nakuba ubunzima bobuchwepheshe bobunjiniyela bezakhi zofuzo buphezulu kakhulu, okwamanje kuyindlela esetshenziswa kakhulu ekukhiqizweni kwama-antibody amabili ukuze kulungiswe isakhiwo kanye nomsebenzi wama-antibody. Lapho kwenziwa ukwakheka kwama-antibody amabili, isimiso sokusebenza kwama-antibody amabili singasetshenziswa, kodwa ukusabela kwama-antibody amabili kungabangela ukusabela okungekona okuqondile, ngakho-ke kuzocatshangelwa ngokucophelela ekusetshenzisweni okusebenzayo kokwakheka kwama-antibody amabili, njengokwelashwa kwama-antibody amabili.

Ukuhlanzwa Kwama-Antibodies Ahlukene

Ukuhlanzwa kwe-antibody ye-Bispecific inqubo yokuhlukanisa nokuhlanza ama-antibodies e-target ahlanzekile kakhulu. Izindlela ezimbili, i-centrifugation kanye nokuhlunga okujulile, zisetshenziswa ukususa ukungcola okuncibilikayo. I-antibody ye-target ye-bispecific ibanjwa ekuqaleni yi-affinity chromatography. Kuma-antibodies e-IgG afana ne-bispecific, kusetshenziswa i-protein A affinity chromatography, kuyilapho kuma-antibodies angewona i-IgG afana ne-bispecific, i-light chain based affinity chromatography ingasetshenziswa. Ngemva kwalokho, i-antibody ifakwa ngaphansi kwezimo ze-pH ephansi isikhathi esithile, okwenza isakhiwo seprotheni ebusweni be-virus siphazamiseke, ngaleyo ndlela silahlekelwe ikhono lokuthelela amaseli. Ukuhlunga okujulile okuphakathi kwenziwa ukuze kususwe ukungcola okufana nama-protein e-host cell (HCP). Ubumsulwa bama-antibodies buyathuthukiswa ngezindlela ezifana ne-ion exchange chromatography, futhi noma yimaphi amagciwane asele asuswa ngokusebenzisa amasu e-nanofiltration noma i-ultrafiltration. Ekugcineni, isampula igxilisiwe futhi ithathelwe indawo yi-buffer efanele yokwakheka.

Ukuhamba Kwesevisi Yokukhiqiza Ama-Antibodies Ahlukene Ahlukene

Izinyathelo Okuqukethwe Kwesevisi Umugqa wesikhathi
Ukwenziwa Kwezakhi Zofuzo
Ukukhiqizwa kwezinhlelo zokuklama ezifika kwezingu-3 ezahlukene, ukukhiqizwa okusha kwama-recombinant antibody DNA plasmids
Amaviki ama-2-3
Ukuhlolwa Kwezinga Elincane Ukukhiqizwa kwamaprotheni e-antibody amabili → Ukubonakaliswa okuncane emigqeni yamaseli ezilwane ezincelisayo → Ukuqinisekiswa yi-SDS-PAGE → Ukuhlaziywa kokubopha ngama-antigen e-protein aphinde ahlanganiswe yi-ELISA → Ukuqhathaniswa kwama-clones nama-antibodies abazali Amaviki ama-5-6
Khomba
Ukuvezwa kwama-antibodies amabili okuqala aphelele e-bispecific → Ukuhlaziywa kokubopha yi-ELISA → Ukuhlolwa kwe-ELISA kwama-antibodies aqashelwa ama-antibody egundane
Isonto eli-1
Ukukhiqizwa Kwama-Antibody
Ukukhiqizwa kwama-antibody amakhulu
Amaviki angu-3-4

Izinzuzo Zethu

Sihlanganisa izinsizakalo zokukhiqizwa kwama-antibody ezisezingeni eliphezulu nezisezingeni eliphansi, futhi singahlinzeka ngezinsizakalo zobuchwepheshe kusukela ekulungiseleleni ama-antibody, ukuhlanzwa kwama-antibody amabili kanye nokuhlukaniswa nokuhlanzwa kwama-antibody, ukulandelana kwama-antibody, ukuqinisekiswa kwama-antibody, njll., ezingasetshenziswa ekwelashweni kwama-antibody amabili.

  • i-dst-11

    Ukuvezwa Okuphezulu

    Ukuvezwa okuphezulu kwamaprotheni kumaseli e-CHO.

  • i-dst-12

    Isitoreji Esizinzile

    > Amaviki ama-2 ku-serum ku-37°C.

  • i-dst-13

    Ayikho Inkinga Yokuncibilika

    >30 mg/ml

  • i-dst-14

    Amaseli Aqinile

    Kuye kwasungulwa imigqa eminingi yamaseli azinzile anama-antigen esimila ukuze kuqinisekiswe ama-antibodies amaningi e-bispecific

Isevisi Ehlobene

Uma unemibuzo, sicela ukhululeke ukuxhumana nathi nganoma yisiphi isikhathi.

Leave Your Message

Isevisi Evelele